1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, revised 2017. [cited 2017 May 17]. Availablefrom: www.ginaasthma.org.
2. Nenasheva N. M. Novye vozmozhnosti dostizheniya kontrolya astmy s pomosch'yu tiotropiya bromida // Ehffektivnaya farmakoterapiya. – 2014. – № 29. – S. 4–13. [Nenasheva N. M. New possibilities to achieve asthma control with tiotropium bromide // Effective pharmacotherapy. – 2014. – No. 29. – P. 4–13].
3. Churyukina Eh. V., Sizyakina L. P. Patogeneticheskie aspekty formirovaniya razlichnykh variantov bronkhial'noj astmy // Rossijskij allergologicheskij zhurnal. – 2017. – № 1. – S. 194–196. [Churyukina E.V., Sizyakina L. P. Pathogenetic aspects of formation of various variants of bronchial asthma // Russian allergological journal. – 2017. – No. 1. – P. 194–196].
4. Barnes P. J. Tiotropium bromide // Expert Opin. Investig. Drugs. 2001. Vol. 10. № 4. P. 733–740.
5. Churyukina Eh. V., Goloshubova E. A. Optimizatsiya algoritma spirometricheskoj verifikatsii diagnoza bronkhial'noj astmy // Rossijskij immunologicheskij zhurnal. – 2015. – T. 9. № 5 – S. 240. [Churyukina E.V., Goloshubova E. A. Optimization of the algorithm for spirometric verifi cation of the diagnosis of bronchial asthma // Russian Immunological Journal. – 2015. – V .9. № 5 – S. 240].